isoliquiritigenin

Isoliquiritigenin is a lipid of Polyketides (PK) class. Isoliquiritigenin is associated with abnormalities such as abnormal fragmented structure, Gastric ulcer, Gastric mucosa lesion, Peptic Ulcer and Wiskott-Aldrich Syndrome. The involved functions are known as Mass-to-Charge Ratio, Anabolism, Oxidation, inhibitors and Energy Absorption. Isoliquiritigenin often locates in Microsomes, Liver, Hepatic, Microsomes, Immune system and Vacuole. The associated genes with Isoliquiritigenin are P4HTM gene, BCL2 gene, AP1AR gene, oxytocin, 1-desamino-(O-Et-Tyr)(2)- and ODAM gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of isoliquiritigenin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with isoliquiritigenin?

isoliquiritigenin is suspected in Gastric mucosa lesion, Gastric ulcer, Peptic Ulcer, Nodule, Infertility and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with isoliquiritigenin

MeSH term MeSH ID Detail
Carcinoma, Adenoid Cystic D003528 3 associated lipids
Choroidal Neovascularization D020256 5 associated lipids
Leiomyoma D007889 8 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Precancerous Conditions D011230 48 associated lipids
Weight Loss D015431 56 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Per page 10 20 | Total 13

PubChem Associated disorders and diseases

What pathways are associated with isoliquiritigenin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with isoliquiritigenin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with isoliquiritigenin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with isoliquiritigenin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with isoliquiritigenin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with isoliquiritigenin?

Knock-out

Knock-out are used in the study 'Two activators of in vitro fertilization in mice from licorice.' (Tung NH et al., 2015).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with isoliquiritigenin

Download all related citations
Per page 10 20 50 100 | Total 275
Authors Title Published Journal PubMed Link
Youns M et al. Sensitivity and resistance towards isoliquiritigenin, doxorubicin and methotrexate in T cell acute lymphoblastic leukaemia cell lines by pharmacogenomics. 2010 Naunyn Schmiedebergs Arch. Pharmacol. pmid:20668838
Park SJ and Youn HS Suppression of homodimerization of toll-like receptor 4 by isoliquiritigenin. 2010 Phytochemistry pmid:20701936
Zorko BA et al. Effects of ILTG on DAPK1 promoter methylation in colon and leukemia cancer cell lines. 2010 Anticancer Res. pmid:21036707
Gaur R et al. Liquiritigenin derivatives and their hepatotoprotective activity. 2010 Nat Prod Commun pmid:20839627
Kim YM et al. Inhibition of liver X receptor-α-dependent hepatic steatosis by isoliquiritigenin, a licorice antioxidant flavonoid, as mediated by JNK1 inhibition. 2010 Free Radic. Biol. Med. pmid:20840863
Auyeung KK and Ko JK Novel herbal flavonoids promote apoptosis but differentially induce cell cycle arrest in human colon cancer cell. 2010 Invest New Drugs pmid:19139819
Kang SW et al. Licorice isoliquiritigenin dampens angiogenic activity via inhibition of MAPK-responsive signaling pathways leading to induction of matrix metalloproteinases. 2010 J. Nutr. Biochem. pmid:19157825
Shibano M et al. Determination of flavonoids in licorice using acid hydrolysis and reversed-phase HPLC and evaluation of the chemical quality of cultivated licorice. 2010 Planta Med. pmid:20013636
Choi SH et al. AMPK-mediated GSK3beta inhibition by isoliquiritigenin contributes to protecting mitochondria against iron-catalyzed oxidative stress. 2010 Biochem. Pharmacol. pmid:20026081
Cao L et al. In vitro screening for angiostatic potential of herbal chemicals. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20671276
Park I et al. Isoliquiritigenin induces G2 and M phase arrest by inducing DNA damage and by inhibiting the metaphase/anaphase transition. 2009 Cancer Lett. pmid:19167809
Lee SH et al. Isoliquiritigenin, from Dalbergia odorifera, up-regulates anti-inflammatory heme oxygenase-1 expression in RAW264.7 macrophages. 2009 Inflamm. Res. pmid:19169644
Kwon GT et al. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. 2009 J. Nutr. Biochem. pmid:18824345
Zu Y et al. Cytotoxic activity of isoliquiritigenin towards CCRF-CEM leukemia cells and its effect on DNA damage. 2009 Planta Med. pmid:19291608
Hsu YL et al. Shallot and licorice constituent isoliquiritigenin arrests cell cycle progression and induces apoptosis through the induction of ATM/p53 and initiation of the mitochondrial system in human cervical carcinoma HeLa cells. 2009 Mol Nutr Food Res pmid:19536869
Yoon G et al. Inhibitory effect of chalcones and their derivatives from Glycyrrhiza inflata on protein tyrosine phosphatase 1B. 2009 Bioorg. Med. Chem. Lett. pmid:19632832
Srinivasan B et al. Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities. 2009 J. Med. Chem. pmid:19883086
Park SJ et al. Suppression of the TRIF-dependent signaling pathway of toll-like receptors by isoliquiritigenin in RAW264.7 macrophages. 2009 Mol. Cells pmid:19809799
Lee MJ et al. Protective effects of isoliquiritigenin against methamphetamine-induced neurotoxicity in mice. 2009 J. Pharmacol. Sci. pmid:19834288
Sekine-Osajima Y et al. Two flavonoids extracts from Glycyrrhizae radix inhibit in vitro hepatitis C virus replication. 2009 Hepatol. Res. pmid:18647187